Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

Clinical trial NCT02151695 · COMPLETED

Trial details

NCT number: NCT02151695
Sponsor: Poitiers University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy

Start date: 2015-05-01
Primary completion: 2018-10-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.